Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATP2A2 | P16615 | 1/20 | 0.35 |
| ▸ | ATP2A3 | Q93084 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HPN | P05981 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24344713 | 0.89 | POLB (0.41) | GABRA1GABRB2POLBALDH1A1ALOX15 | |
| SCHEMBL18802806 | 0.84 | GABRA1 (0.39) | GABRA1GABRB2POLBALDH1A1ALOX15 | |
| SCHEMBL21950842 | 0.83 | HIF1A (0.34) | GABRA1GABRB2ALDH1A1ALOX15CYP1A2 | |
| SCHEMBL3178010 | 0.82 | GABRA1 (0.40) | GABRA1GABRB2POLBALDH1A1ALOX15 | |
| SCHEMBL21950844 | 0.80 | GABRA1 (0.33) | GABRA1GABRB2 | |
| SCHEMBL2631798 | 0.80 | SMN1; SMN2 (0.52) | POLBALDH1A1ALOX15MAPTCYP1A2 | |
| SCHEMBL26551956 | 0.79 | NR5A2 (0.33) | ALDH1A1CYP1A2CYP3A4CYP2C9TSHR | |
| SCHEMBL3177948 | 0.76 | GABRA1 (0.36) | GABRA1GABRB2POLBALDH1A1ALOX15 | |
| SCHEMBL11357994 | 0.76 | POLB (0.46) | GABRA1GABRB2POLBALDH1A1ALOX15 | |
| SCHEMBL3176272 | 0.75 | GABRA1 (0.34) | GABRA1GABRB2POLBALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4270108-A1 | CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION AND RESIST PATTERN FORMING PROCESS | Shin-Etsu Chemical Co., Ltd. (JP) | 2023-11-01 | — | — | EP | disclosed |
| EP-4258056-A2 | ALCOHOL COMPOUND, CHEMICALLY AMPLIFIED NEGATIVE RESIST COMPOSITION AND RESIST PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-10-11 | — | — | EP | disclosed |
| EP-4047418-B1 | CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION AND RESIST PATTERN FORMING PROCESS | SHINETSU CHEMICAL CO (JP) | 2023-08-16 | — | — | EP | disclosed |
| US-20220085302-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-03-17 | — | — | US | disclosed |
| WO-2007005676-A2 | ACTIVATOR COMPOSITIONS AND THEIR USE IN CATALYSTS AND OLEFIN POLYMERIZATION | ALBEMARLE CORPORATION (US) | 2007-01-11 | — | — | WO | disclosed |
| WO-2007005921-A2 | BRONSTED ACIDIC ALUMINOXANE COMPOSITIONS AND THEIR USE IN OLEFIN POLYMERIZATION CATALYST COMPOSITIONS | ALBEMARLE CORPORATION (US) | 2007-01-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220085302-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LIFR, LBR, EPOR | GABRA1 460/4885GABRB2 580/4885POLB 2638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.